Affiliated Faculty

Dr. Kelly Barth is a Med-Psych physician board-certified in internal medicine, addiction psychiatry and pain medicine. She directs the MUSC Pain Rehabilitation Program and also performs research in the area of opioid tapering and peer-led interventions for opioid overdose survivors. She is a member of the MUSC Project Echo OUD Hub where she provides mentoring and lectures in the areas of addiction diagnosis and treatment, pain management, and overdose prevention.

Professor
Chandj@musc.edu
Chandler Laboratory

Dr. Cumming's training and research interests are in the study of health related behaviors, especially tobacco use prevention and cessation. His research is primarily population based with a focus on smoking cessation, consumer risk perceptions, the impact of cigarette design on smoking behaviors, and the evaluation of public policies on tobacco use behaviors. Recognized internationally for his work in tobacco epidemiology and smoking cessation, Dr. Cummings has guided global public policy and regulations in the marketing and distribution of nicotine products. This work has involved designing studies to understand factors involved in predicting uptake and cessation of tobacco use and the testing of interventions to alter tobacco use behaviors at both the individual and population level. In 2002, Dr. Cummings established the International Tobacco Research Policy Evaluation Project (ITC Project) to evaluate the behavioral impacts of national level tobacco control policies implemented as part of the WHO Framework Convention on Tobacco Control (FCTC). This international project began in 2002 and involves over 100 scientific colleagues from more than 20 countries and includes a wide range of research projects ranging from those focused on biological factors that influence tobacco use to the impact of health warnings and public education campaigns on representative populations of smokers. As part of his work with the ITC Project he has served as the PI on three large multi-institutional NIH grants (P50 CA111236: 2004-2009, P01 CA138389: 2009-2016, P01 CA200512: 2016-2021).  Data from the ITC Project has become an important source of the evidence base used by governments and public health advocates to support tobacco control policy initiatives around the world. Over his 35-year career he has directed more than 70 grants and contracts and has published over 430 scientific papers including landmark reports for the Office of the Surgeon General, the National Cancer Institute, the International Agency for Research on Cancer, and the Institute of Medicine.

Dr. Danielson's research interests focus on treatment and prevention with high-risk adolescent and traditionally underserved populations, including basic and translational science studies that inform applied clinical research. Her particular areas of research and clinical expertise are in:

1) evaluating and disseminating integrated treatments for comorbid PTSD and substance use problems, as well as HIV sexual risk behaviors, among trauma-exposed adolescents, and

2) understanding the pathways from trauma and stress exposure to mental health problems.

Distinguished University Professor
kalivasp@musc.edu
Kalivas Laboratory

Professor
mcginty@musc.edu
McGinty Laboratory

Professor
mulholl@musc.edu
Mulholland Laboratory

Benjamin Toll, Ph.D., a professor of public health sciences and psychiatry at MUSC, specializes in the treatment of tobacco use disorders and improvement of health behaviors. As associate director, his goal is to provide well-structured and effective education and training opportunities for pre- and post-doctoral students and junior faculty at Hollings Cancer Center.

Professor
woodward@musc.edu
Woodward Laboratory